Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, P. R. China.
Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1259-1264. doi: 10.1080/09273948.2020.1804592. Epub 2020 Nov 13.
To summarize the clinical features and probable factors associated with recurrence within 6 months in northern Chinese ocular toxocariasis (OT) patients.
A retrospective cohort study (38 OT eyes) was conducted. Clinical features, aqueous inflammatory cytokines, complications, and parameters associated with recurrence after treatment were analyzed.
The initial best-corrected visual acuity (BCVA) was related to the anterior inflammation grade at the onset ( = .028). The mean BCVA and anterior inflammation improved significantly ( < .05) after treatment. The OT eyes had higher aqueous humor cytokine levels (IL-6, IL-8, and IL-10) compared with the normal eyes ( < .001). More severe anterior inflammation grade or longer duration of uveitis were more likely to increase the probability of recurrence ( = .008 and = .025), TA injection during/after vitreous surgery can reduce the probability of recurrence ( = .031).
The combination therapy of vitreoretinal surgery, steroids, and albendazole therapy may reduce inflammation and recurrence of OT effectively. BCVA: best-corrected visual acuity; BFGF: basic fibroblast growth factor; CFT: central foveal thickness; CI: confidence interval; ELISA: Enzyme-linked immunosorbent assay; ERM: epiretinal membrane; IOP: intraocular pressure; IQR: interquartile range; IL: interleukin; LFM: laser flare meter; MH: macular hole; OCT: optical coherence tomography; OR: odds ratio; OT: ocular toxocariasis; RD: retinal detachment; TA: triamcinolone acetonide; TCLA: Toxocara canis larva crude antigen; TGF: transforming growth factor; VCAM: vascular cell adhesion molecule; VEGF: vascular endothelial growth factor.
总结中国北方眼弓蛔虫病(OT)患者 6 个月内复发的临床特征和可能相关因素。
进行了一项回顾性队列研究(38 只 OT 眼)。分析了治疗后与复发相关的临床特征、房水炎性细胞因子、并发症和参数。
初始最佳矫正视力(BCVA)与发病时的前房炎症分级有关( = 0.028)。治疗后 BCVA 和前房炎症明显改善( < 0.05)。OT 眼房水中细胞因子水平(IL-6、IL-8 和 IL-10)高于正常眼( < 0.001)。更严重的前房炎症分级或更长时间的葡萄膜炎更有可能增加复发的概率( = 0.008 和 = 0.025),玻璃体内注射 TA 可降低复发的概率( = 0.031)。
玻璃体视网膜手术、类固醇和阿苯达唑联合治疗可能有效减轻 OT 的炎症和复发。BCVA:最佳矫正视力;BFGF:碱性成纤维细胞生长因子;CFT:中央凹厚度;CI:置信区间;ELISA:酶联免疫吸附试验;ERM:视网膜内膜;IOP:眼内压;IQR:四分位距;IL:白细胞介素;LFM:激光闪烁计;MH:黄斑裂孔;OCT:光学相干断层扫描;OR:比值比;OT:眼弓蛔虫病;RD:视网膜脱离;TA:曲安奈德;TCLA:犬弓蛔虫幼虫粗抗原;TGF:转化生长因子;VCAM:血管细胞黏附分子;VEGF:血管内皮生长因子。